Skip to content
lifestyle.streetregister.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
SimBioSys
SimBioSys Secures FDA Clearance for TumorSight® Risk, Introducing the World’s First AI-Powered, MRI-Derived Breast Cancer Recurrence Risk Assessment
October 18, 2026
SimBioSys and Venture Café Phoenix Partner to Present Live Panel on AI, Innovation and the Future of Breast Cancer Care
September 22, 2026
SimBioSys and Ferrum Health Partner to Expand Access to AI-Powered Surgical Planning Through Ferrum’s AI Governance Suite
July 23, 2026